Akebia Therapeutics Inc. (AKBA) News Nov 20, 2014,
Post# of 250601
Posted On: 11/21/2014 4:08:56 AM
Akebia Therapeutics Inc. (AKBA) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on AKBA
4 stocks to watch 2:33 p.m. April 16, 2014 - The Trading Deck
Biotech IPOs manage double-digit gains on first days of trading 11:47 a.m. March 21, 2014 - Russ Britt
Other News on AKBA
10-Q: AKEBIA THERAPEUTICS, INC. 7:03 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Akebia renal anemia drug successful in Phase 2 6:13 a.m. Oct. 27, 2014 - Seeking Alpha
First patient dosed in Phase 2 trial of Akebia's lead product 9:59 a.m. Sept. 25, 2014 - Seeking Alpha
Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% - Tale of the Tape 7:57 a.m. Sept. 16, 2014 - Zacks.com
Others Overlooked Akebia Therapeutics (AKBA), Should You Buy It Now? - Tale of the Tape 7:45 a.m. Sept. 15, 2014 - Zacks.com
Significant Sell-Off Could Occur For Akebia Therapeutics At Lockup Expiration 4:50 p.m. Sept. 3, 2014 - Seeking Alpha
Can the Uptrend Continue for Akebia (AKBA)? - Tale of the Tape 8:33 a.m. Aug. 18, 2014 - Zacks.com
10-Q: AKEBIA THERAPEUTICS, INC. 6:28 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hidden Value From Abnormal Insider Buying Activity 3:54 a.m. June 10, 2014 - Seeking Alpha
10-Q: AKEBIA THERAPEUTICS, INC. 6:08 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Halliburton Feels The Turn (4/22/14) 5:08 a.m. April 23, 2014 - Seeking Alpha
Why Akebia Therapeutics (AKBA) Stock Soared Today 3:21 p.m. April 14, 2014 - TheStreet.com
Weekly CEO Buys Highlight: BH, OPK, ARCP, RSE, AKBA 5:02 p.m. April 1, 2014 - GuruFocus.com
IPO Sizzle Continues With A10 Networks Set For Friday 12:03 p.m. March 20, 2014 - Investors Business Daily
Press Releases on AKBA
Akebia Therapeutics President and Chief Executive Officer Establishes Stock Purchase Plan 7:01 a.m. Nov. 17, 2014 - BusinessWire - BZX
Akebia Announces Poster Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting 7:00 a.m. Nov. 11, 2014 - BusinessWire - BZX
Akebia Announces Third Quarter 2014 Financial Results 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Oct. 31, 2014 - BusinessWire - BZX
Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease 5:30 a.m. Oct. 27, 2014 - BusinessWire - BZX
Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis 6:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Ronald C. Renaud Jr. to its Board of Directors 6:15 a.m. Sept. 15, 2014 - BusinessWire - BZX
Akebia Therapeutics, Inc. (NASDAQ: AKBA) to Ring The NASDAQ Stock Market Opening Bell 9:00 a.m. Sept. 11, 2014 - GlobeNewswire
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Aug. 27, 2014 - BusinessWire - BZX
Akebia Announces Second Quarter 2014 Financial Results 6:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Expansion of Management Team 6:01 a.m. Aug. 6, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Michael Clayman, M.D. and Maxine Gowen, Ph.D. to its Board of Directors 6:02 a.m. July 17, 2014 - BusinessWire - BZX
Akebia Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Upcoming Presentation at 51st ERA-EDTA Annual Congress 6:02 a.m. May 29, 2014 - BusinessWire - BZX
Akebia to Present at the Annual UBS Global Healthcare Conference 8:32 a.m. May 12, 2014 - BusinessWire - BZX
Akebia Announces First Quarter 2014 Financial Results and Recent Corporate Highlights 6:01 a.m. May 12, 2014 - BusinessWire - BZX
Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics 7:00 a.m. April 23, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Aruba Networks, Akebia Therapeutics, bebe stores, and Allscripts Healthcare Solutions 11:03 a.m. April 15, 2014 - PR Newswire - PRF
Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548 8:21 a.m. April 15, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 7:02 a.m. March 26, 2014 - BusinessWire - BZX
MarketWatch News on AKBA
4 stocks to watch 2:33 p.m. April 16, 2014 - The Trading Deck
Biotech IPOs manage double-digit gains on first days of trading 11:47 a.m. March 21, 2014 - Russ Britt
Other News on AKBA
10-Q: AKEBIA THERAPEUTICS, INC. 7:03 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Akebia renal anemia drug successful in Phase 2 6:13 a.m. Oct. 27, 2014 - Seeking Alpha
First patient dosed in Phase 2 trial of Akebia's lead product 9:59 a.m. Sept. 25, 2014 - Seeking Alpha
Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% - Tale of the Tape 7:57 a.m. Sept. 16, 2014 - Zacks.com
Others Overlooked Akebia Therapeutics (AKBA), Should You Buy It Now? - Tale of the Tape 7:45 a.m. Sept. 15, 2014 - Zacks.com
Significant Sell-Off Could Occur For Akebia Therapeutics At Lockup Expiration 4:50 p.m. Sept. 3, 2014 - Seeking Alpha
Can the Uptrend Continue for Akebia (AKBA)? - Tale of the Tape 8:33 a.m. Aug. 18, 2014 - Zacks.com
10-Q: AKEBIA THERAPEUTICS, INC. 6:28 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hidden Value From Abnormal Insider Buying Activity 3:54 a.m. June 10, 2014 - Seeking Alpha
10-Q: AKEBIA THERAPEUTICS, INC. 6:08 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Halliburton Feels The Turn (4/22/14) 5:08 a.m. April 23, 2014 - Seeking Alpha
Why Akebia Therapeutics (AKBA) Stock Soared Today 3:21 p.m. April 14, 2014 - TheStreet.com
Weekly CEO Buys Highlight: BH, OPK, ARCP, RSE, AKBA 5:02 p.m. April 1, 2014 - GuruFocus.com
IPO Sizzle Continues With A10 Networks Set For Friday 12:03 p.m. March 20, 2014 - Investors Business Daily
Press Releases on AKBA
Akebia Therapeutics President and Chief Executive Officer Establishes Stock Purchase Plan 7:01 a.m. Nov. 17, 2014 - BusinessWire - BZX
Akebia Announces Poster Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting 7:00 a.m. Nov. 11, 2014 - BusinessWire - BZX
Akebia Announces Third Quarter 2014 Financial Results 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Oct. 31, 2014 - BusinessWire - BZX
Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease 5:30 a.m. Oct. 27, 2014 - BusinessWire - BZX
Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis 6:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Ronald C. Renaud Jr. to its Board of Directors 6:15 a.m. Sept. 15, 2014 - BusinessWire - BZX
Akebia Therapeutics, Inc. (NASDAQ: AKBA) to Ring The NASDAQ Stock Market Opening Bell 9:00 a.m. Sept. 11, 2014 - GlobeNewswire
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Aug. 27, 2014 - BusinessWire - BZX
Akebia Announces Second Quarter 2014 Financial Results 6:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Expansion of Management Team 6:01 a.m. Aug. 6, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Michael Clayman, M.D. and Maxine Gowen, Ph.D. to its Board of Directors 6:02 a.m. July 17, 2014 - BusinessWire - BZX
Akebia Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Upcoming Presentation at 51st ERA-EDTA Annual Congress 6:02 a.m. May 29, 2014 - BusinessWire - BZX
Akebia to Present at the Annual UBS Global Healthcare Conference 8:32 a.m. May 12, 2014 - BusinessWire - BZX
Akebia Announces First Quarter 2014 Financial Results and Recent Corporate Highlights 6:01 a.m. May 12, 2014 - BusinessWire - BZX
Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics 7:00 a.m. April 23, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Aruba Networks, Akebia Therapeutics, bebe stores, and Allscripts Healthcare Solutions 11:03 a.m. April 15, 2014 - PR Newswire - PRF
Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548 8:21 a.m. April 15, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 7:02 a.m. March 26, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼